The coronavirus (COVID-19) pandemic is a significant psychological stressor that threatens the onset of a mental health crisis in the US. Fear and anxiety about COVID-19 and its economic impact, as well as loneliness due to the required social isolation, are driving the mental health impacts of COVID-19; in a recent Kaiser Family Foundation poll, 45% of respondents reported that the coronavirus has had a negative impact on their mental health. This is reflected in Southeastern Ohio. In data that the investigators collected from 317 Ohio University faculty, staff, and students from late May to early June, 39% reported moderate-to-severe levels of anxiety, 41% reported moderate-to-severe levels of depression and 57% reported the COVID-19 outbreak was impacting their sense of social connection much or very much. Despite the significant community need for accessible and affordable care, there are currently no evidence-based interventions for individuals coping poorly with coronavirus-related distress. The investigators have developed a virtual group-based intervention targeting cognitive biases that amplify the experience of stress and anxiety (i.e., amplifying cognitions; Coping with Coronavirus-Related Emotion and Worry \[COPING CREW\]). The next step in developing this intervention in a scientifically rigorous manner is to refine the manual and procedures and conduct a pilot test of the intervention.
There is a coming mental health crisis in response to the COVID-19 pandemic. Already, rates of depression, anxiety, and suicide are elevated in response to the pandemic. A recent study of more than 5,400 people in the US found prevalence rates of anxiety and depression in June of 2020 were 3-4 times higher than these rates in June of 2019. In this same study, 41% of respondents in June 2020 reported experiencing an adverse mental or behavioral health condition, including 13% who endorsed using substances to cope with stress or emotions and 11% who reported seriously contemplating suicide in the prior 30 days. Thus, heightened anxiety, stress, and depression will likely continue to lead to increases in self-harm and maladaptive substance use if left unchecked. It is crucial that empirically validated psychotherapies be developed to meet these needs. These treatments must address how common barriers to treatment, including time, cost, transportation, and stigma about mental health may be exacerbated by the pandemic. The investigators developed a brief, virtual group-based intervention, framed as educational, Coping with Coronavirus-Related Emotions and Worries (COPING CREW), to address these barriers. This intervention was developed over the summer by Drs. Allan, Suhr, and Austin, working with two graduate student research assistants for administration by clinical psychology graduate student therapists as part of their practicum experience at the Ohio University Psychology and Social Work Clinic (PSWC). A benefit of this approach, therefore, is that this intervention is highly scalable. Theoretical models posit the short- and long-term stressors experienced during the pandemic exacerbate the experience of negative emotions an individual is already predisposed to experience. That is, people who are already experiencing mental health issues are going to experience more severe issues and people who may not already be experiencing mental health issues are more likely to develop mental health issues during the pandemic. Cognitive risk factors (i.e., amplifying cognitions) such as anxiety sensitivity (fear of anxiety sensations), intolerance of uncertainty (fear of the unknown), and loneliness (the subjective feeling of isolation) increase the experience of negative emotions as well as the likelihood of unhealthy coping behavior such as increased alcohol consumption or self-harm. Anxiety sensitivity, intolerance of uncertainty, and loneliness can be reduced through brief interventions applying cognitive-behavioral therapy principles. Reductions in these constructs lead to later reductions in anxiety, depression, and suicide. Targeting these risk factors appears critical to address distress due to COVID-19. In 317 Ohio University faculty, staff, and students, anxiety sensitivity, intolerance of uncertainty, and loneliness accounted for 63%-75% of the variance in ratings of anxiety, depression, and suicidality as well as 49% of COVID-related disability. These findings highlight the prominent role these risk factors play in the distress many individuals are experiencing due to COVID-19. The investigators have developed a virtual group-based intervention targeting risk factors that amplify the experience of emotional distress; the next steps in developing a scientifically rigorous intervention that can be disseminated broadly is to develop and pilot test this intervention. The goals specific to this project are to 1) engage stakeholders in the design of a brief group-based treatment to improve COPING CREW and 2) to conduct a Stage I pilot trial through evaluating the acceptability and feasibility of COPING CREW. Aim 1: Refine a prototype for COPING CREW by working virtually with a community partner stakeholder advisory group (SAG) as well as participants receiving the intervention. The investigators will develop a SAG comprising one participant from each community partner. The investigators will meet with the SAG at least three times during the 1-year project. Meetings will occur prior to starting COPING CREW groups, after running the first two groups, and after all four groups have been completed. The investigators anticipate that building a strong relationship with this SAG will increase treatment relevance to clientele, treatment engagement, and treatment dissemination. In turn, this will enhance the durable impacts and sustainability of COPING CREW. In addition to SAGs, the investigators will also utilize a systematic approach to engage with participant stakeholders by asking for feedback about the intervention (the Exit Interview). The investigators have used these intervention modules separately a number of times but have yet to examine these modules as part of the same intervention. Thus, participants will provide important information on how to tailor the intervention, including the order of the components, the amount of homework specific to each component, and the length of time before the booster session to best meet their needs. Although the investigators are confident that COPING CREW will largely be viewed as acceptable, it can be modified to increase acceptability by effective engagement with community partners. Solicitation of feedback will occur via two mechanisms. First, information related to adaptation will be obtained from quantitative and qualitative feedback during the intervention. Second, information related to adaptation and engagement will also be collected in separate, focused feedback sessions with COPING CREW participants. Aim 2: Examine acceptability and feasibility of COPING CREW, delivered virtually. A pilot one arm trial will be conducted, delivering the intervention to 24 participants across 4 groups. H1: It is hypothesized that the intervention will demonstrate high acceptability and feasibility (as measured by completion rates and favorable ratings of satisfaction) across intervention modules and components within sessions. Components will include psychoeducation, challenging cognitive biases or mythbusting, behavioral exposure, behavioral experiments, and ecological momentary intervention (EMI) for treatment monitoring and homework tracking.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
24
Coping Crew consists of five 60-minute virtual intervention sessions coinciding with five weeks of EMI. Participants will receive psychoeducation, challenge cognitive biases or mythbust, and participate in behavioral exposure and behavioral experiments. An EMI component of this treatment will be included for the purpose of treatment monitoring and homework tracking. Participation in this EMI component involves the daily report of levels of anxiety, depression, stress, and loneliness. When participants endorse elevated levels on any of these constructs, they will receive a targeted message reminding them of the topics covered in COPING CREW. One month after the intervention session, COPING CREW participants will complete follow-up questionnaires and interview. Participants will also participate in a feedback session 3 months after the intervention.
Ohio University
Athens, Ohio, United States
RECRUITINGSatisfaction with the intervention as assessed by Client Satisfaction Questionnaire-8
The Client Satisfaction Questionnaire-8 is a 8-item self-report scale that assesses client satisfaction with a particular intervention/program. The Client Satisfaction Questionnaire-8 is completed by rating satisfaction with services on a 1-4 Likert-type scale. Possible total scores range from 8 to 32. Greater satisfaction is indicated by higher scores.
Time frame: Immediately after the intervention
Feasibility of service as assessed by response rates for the Ecological Momentary Assessment/Ecological Momentary Intervention component of the intervention
Feasibility will also be determined based on response rates for Ecological Momentary Assessment/Ecological Momentary Intervention. If 80% of participants respond to 80% of the EMA prompts, this will be considered a feasible means of service delivery.
Time frame: 5-week EMA/EMI, During the Intervention (Weeks 1-5)
COVID-19 Impact Battery - Behavior
This 12-item scale was created to measure behavioral patterns in response to the COVID-19 outbreak. Participants responded to this scale by rating the extent to which they "have engaged in the following behaviors in response to COVID-19" using a five-point scale (from 0 = "Not at all" to 4 = "Very much"). Each of the potential behaviors listed in this scale (e.g., "Using hand sanitizer") were rated by participants. Possible total scores range from 0 to 48. A higher rate of engagement in the listed behaviors is indicated by a higher score.
Time frame: Baseline, pre-intervention
COVID-19 Impact Battery - Behavior
This 12-item scale was created to measure behavioral patterns in response to the COVID-19 outbreak. Participants responded to this scale by rating the extent to which they "have engaged in the following behaviors in response to COVID-19" using a five-point scale (from 0 = "Not at all" to 4 = "Very much"). Each of the potential behaviors listed in this scale (e.g., "Using hand sanitizer") were rated by participants. Possible total scores range from 0 to 48. A higher rate of engagement in the listed behaviors is indicated by a higher score.
Time frame: Immediately after the intervention
COVID-19 Impact Battery - Behavior
This 12-item scale was created to measure behavioral patterns in response to the COVID-19 outbreak. Participants responded to this scale by rating the extent to which they "have engaged in the following behaviors in response to COVID-19" using a five-point scale (from 0 = "Not at all" to 4 = "Very much"). Each of the potential behaviors listed in this scale (e.g., "Using hand sanitizer") were rated by participants. Possible total scores range from 0 to 48. A higher rate of engagement in the listed behaviors is indicated by a higher score.
Time frame: Follow-Up, 1 month after the intervention
COVID-19 Impact Battery - Behavior
This 12-item scale was created to measure behavioral patterns in response to the COVID-19 outbreak. Participants responded to this scale by rating the extent to which they "have engaged in the following behaviors in response to COVID-19" using a five-point scale (from 0 = "Not at all" to 4 = "Very much"). Each of the potential behaviors listed in this scale (e.g., "Using hand sanitizer") were rated by participants. Possible total scores range from 0 to 48. A higher rate of engagement in the listed behaviors is indicated by a higher score.
Time frame: Follow-Up, 3 months after the intervention
COVID-19 Impact Battery - Worry
This 11-item scale was created to measure worry and distress in response to the outbreak of COVID-19. The items on this measure use a five-point scale (from 0 = "Not at all" to 4 = "Very Much"). Participants used this scale to rate each item (e.g., "I worry that I will lose my employment") based on the degree to which it has caused distress. Possible total scores range from 0 to 44. Greater worry and distress is indicated by higher scores.
Time frame: Baseline, pre-intervention
COVID-19 Impact Battery - Worry
This 11-item scale was created to measure worry and distress in response to the outbreak of COVID-19. The items on this measure use a five-point scale (from 0 = "Not at all" to 4 = "Very Much"). Participants used this scale to rate each item (e.g., "I worry that I will lose my employment") based on the degree to which it has caused distress. Possible total scores range from 0 to 44. Greater worry and distress is indicated by higher scores.
Time frame: Immediately after the intervention
COVID-19 Impact Battery - Worry
This 11-item scale was created to measure worry and distress in response to the outbreak of COVID-19. The items on this measure use a five-point scale (from 0 = "Not at all" to 4 = "Very Much"). Participants used this scale to rate each item (e.g., "I worry that I will lose my employment") based on the degree to which it has caused distress. Possible total scores range from 0 to 44. Greater worry and distress is indicated by higher scores.
Time frame: Follow-Up, 1 month after the intervention
COVID-19 Impact Battery - Worry
This 11-item scale was created to measure worry and distress in response to the outbreak of COVID-19. The items on this measure use a five-point scale (from 0 = "Not at all" to 4 = "Very Much"). Participants used this scale to rate each item (e.g., "I worry that I will lose my employment") based on the degree to which it has caused distress. Possible total scores range from 0 to 44. Greater worry and distress is indicated by higher scores.
Time frame: Follow-Up, 3 months after the intervention
COVID-19 Impact Battery - Disability
This 7-item scale was created to measure the presence of difficulties in response to the outbreak of COVID-19. Participants were asked to rate difficulties on a five-point scale from 0 ("None") to 4 ("Extreme or cannot do"). Participants used this scale to rate the degree of difficulties experienced in the preceding 30 days because of the COVID-19 outbreak. Possible total scores range from 0 to 28. A greater rate of disability is indicated by a higher score.
Time frame: Baseline, pre-intervention
COVID-19 Impact Battery - Disability
This 7-item scale was created to measure the presence of difficulties in response to the outbreak of COVID-19. Participants were asked to rate difficulties on a five-point scale from 0 ("None") to 4 ("Extreme or cannot do"). Participants used this scale to rate the degree of difficulties experienced in the preceding 30 days because of the COVID-19 outbreak. Possible total scores range from 0 to 28. A greater rate of disability is indicated by a higher score.
Time frame: Immediately after the intervention
COVID-19 Impact Battery - Disability
This 7-item scale was created to measure the presence of difficulties in response to the outbreak of COVID-19. Participants were asked to rate difficulties on a five-point scale from 0 ("None") to 4 ("Extreme or cannot do"). Participants used this scale to rate the degree of difficulties experienced in the preceding 30 days because of the COVID-19 outbreak. Possible total scores range from 0 to 28. A greater rate of disability is indicated by a higher score.
Time frame: Follow-Up, 1 month after the intervention
COVID-19 Impact Battery - Disability
This 7-item scale was created to measure the presence of difficulties in response to the outbreak of COVID-19. Participants were asked to rate difficulties on a five-point scale from 0 ("None") to 4 ("Extreme or cannot do"). Participants used this scale to rate the degree of difficulties experienced in the preceding 30 days because of the COVID-19 outbreak. Possible total scores range from 0 to 28. A greater rate of disability is indicated by a higher score.
Time frame: Follow-Up, 3 months after the intervention
COVID-19 Items
Investigator-created questions assessing demographic information related to the COVID-19 pandemic will be administered.
Time frame: Baseline, pre-intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) anxiety scale
The PROMIS Anxiety scale is an 8-item scale that measures anxiety broadly, including items to assess fear, anxious misery, hyperarousal, and somatic symptoms. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater anxiety is indicated by higher scores.
Time frame: Baseline, pre-intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) anxiety scale
The PROMIS Anxiety scale is an 8-item scale that measures anxiety broadly, including items to assess fear, anxious misery, hyperarousal, and somatic symptoms. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater anxiety is indicated by higher scores.
Time frame: During the Intervention (Weeks 1-5)
Patient-Reported Outcomes Measurement Information System (PROMIS) anxiety scale
The PROMIS Anxiety scale is an 8-item scale that measures anxiety broadly, including items to assess fear, anxious misery, hyperarousal, and somatic symptoms. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater anxiety is indicated by higher scores.
Time frame: Immediately after the intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) anxiety scale
The PROMIS Anxiety scale is an 8-item scale that measures anxiety broadly, including items to assess fear, anxious misery, hyperarousal, and somatic symptoms. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater anxiety is indicated by higher scores.
Time frame: Follow-Up, 1 month after the intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) anxiety scale
The PROMIS Anxiety scale is an 8-item scale that measures anxiety broadly, including items to assess fear, anxious misery, hyperarousal, and somatic symptoms. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater anxiety is indicated by higher scores.
Time frame: Follow-Up, 3 months after the intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) depression scale
The PROMIS Depression scale is an 8-item scale that measures depression. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater depression is indicated by higher scores.
Time frame: Baseline, pre-intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) depression scale
The PROMIS Depression scale is an 8-item scale that measures depression. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater depression is indicated by higher scores.
Time frame: During the Intervention (Weeks 1-5)
Patient-Reported Outcomes Measurement Information System (PROMIS) depression scale
The PROMIS Depression scale is an 8-item scale that measures depression. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater depression is indicated by higher scores.
Time frame: Immediately after the intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) depression scale
The PROMIS Depression scale is an 8-item scale that measures depression. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater depression is indicated by higher scores.
Time frame: Follow-Up, 1 month after the intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) depression scale
The PROMIS Depression scale is an 8-item scale that measures depression. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater depression is indicated by higher scores.
Time frame: Follow-Up, 3 months after the intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) stress scale
The PROMIS Psychological Stress scale is an 8-item scale that measures feelings about self and the world in the context of challenges. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater stress is indicated by higher scores.
Time frame: Baseline, pre-intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) stress scale
The PROMIS Psychological Stress scale is an 8-item scale that measures feelings about self and the world in the context of challenges. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater stress is indicated by higher scores.
Time frame: During the Intervention (Weeks 1-5)
Patient-Reported Outcomes Measurement Information System (PROMIS) stress scale
The PROMIS Psychological Stress scale is an 8-item scale that measures feelings about self and the world in the context of challenges. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater stress is indicated by higher scores.
Time frame: Immediately after the intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) stress scale
The PROMIS Psychological Stress scale is an 8-item scale that measures feelings about self and the world in the context of challenges. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater stress is indicated by higher scores.
Time frame: Follow-Up, 1 month after the intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) stress scale
The PROMIS Psychological Stress scale is an 8-item scale that measures feelings about self and the world in the context of challenges. Items are on a 5-point scale from 1 (Never) to 5 (Always). Possible total scores range from 8 to 40. Greater stress is indicated by higher scores.
Time frame: Follow-Up, 3 months after the intervention
Anxiety Sensitivity Index 3 (ASI-3)
18-item self-report measure of anxiety sensitivity. This scale was developed to provide a more stable measure of the three most widely recognized AS subfactors (cognitive, social and physical concerns) than the previous ASIs provided. The ASI-3 will be utilized to assess level of overall anxiety sensitivity. Participants are asked to rate the degree to which anxiety symptoms are distressing on a five-point scale from 0 ("Very Little") to 4 ("Very Much"). Possible total scores range from 0 to 72. Greater distress is indicated by higher scores.
Time frame: Baseline, pre-intervention
Anxiety Sensitivity Index 3 (ASI-3)
18-item self-report measure of anxiety sensitivity. This scale was developed to provide a more stable measure of the three most widely recognized AS subfactors (cognitive, social and physical concerns) than the previous ASIs provided. The ASI-3 will be utilized to assess level of overall anxiety sensitivity. Participants are asked to rate the degree to which anxiety symptoms are distressing on a five-point scale from 0 ("Very Little") to 4 ("Very Much"). Possible total scores range from 0 to 72. Greater distress is indicated by higher scores.
Time frame: During the Intervention (Weeks 1-5)
Anxiety Sensitivity Index 3 (ASI-3)
18-item self-report measure of anxiety sensitivity. This scale was developed to provide a more stable measure of the three most widely recognized AS subfactors (cognitive, social and physical concerns) than the previous ASIs provided. The ASI-3 will be utilized to assess level of overall anxiety sensitivity. Participants are asked to rate the degree to which anxiety symptoms are distressing on a five-point scale from 0 ("Very Little") to 4 ("Very Much"). Possible total scores range from 0 to 72. Greater distress is indicated by higher scores.
Time frame: Immediately after the intervention
Anxiety Sensitivity Index 3 (ASI-3)
18-item self-report measure of anxiety sensitivity. This scale was developed to provide a more stable measure of the three most widely recognized AS subfactors (cognitive, social and physical concerns) than the previous ASIs provided. The ASI-3 will be utilized to assess level of overall anxiety sensitivity. Participants are asked to rate the degree to which anxiety symptoms are distressing on a five-point scale from 0 ("Very Little") to 4 ("Very Much"). Possible total scores range from 0 to 72. Greater distress is indicated by higher scores.
Time frame: Follow-Up, 1 month after the intervention
Anxiety Sensitivity Index 3 (ASI-3)
18-item self-report measure of anxiety sensitivity. This scale was developed to provide a more stable measure of the three most widely recognized AS subfactors (cognitive, social and physical concerns) than the previous ASIs provided. The ASI-3 will be utilized to assess level of overall anxiety sensitivity. Participants are asked to rate the degree to which anxiety symptoms are distressing on a five-point scale from 0 ("Very Little") to 4 ("Very Much"). Possible total scores range from 0 to 72. Greater distress is indicated by higher scores.
Time frame: Follow-Up, 3 months after the intervention
Intolerance of Uncertainty-12
This scale is a 12-item scale for measuring trait Intolerance of Uncertainty. it is used for assessing the degree to which individuals are able to tolerate the uncertainty of ambiguous situations, the cognitive and behavioral responses to uncertainty, perceived implications of uncertainty, and attempts to control the future. This scale uses a five-point, Likert-type scale ranging from 1 ("Not at all characteristic of me") to 5 ("Entirely characteristic of me"). Possible total scores range from 12 to 60. Greater uncertainty is indicated by higher scores.
Time frame: Baseline, pre-intervention
Intolerance of Uncertainty-12
This scale is a 12-item scale for measuring trait Intolerance of Uncertainty. it is used for assessing the degree to which individuals are able to tolerate the uncertainty of ambiguous situations, the cognitive and behavioral responses to uncertainty, perceived implications of uncertainty, and attempts to control the future. This scale uses a five-point, Likert-type scale ranging from 1 ("Not at all characteristic of me") to 5 ("Entirely characteristic of me"). Possible total scores range from 12 to 60. Greater uncertainty is indicated by higher scores.
Time frame: During the Intervention (Weeks 1-5)
Intolerance of Uncertainty-12
This scale is a 12-item scale for measuring trait Intolerance of Uncertainty. it is used for assessing the degree to which individuals are able to tolerate the uncertainty of ambiguous situations, the cognitive and behavioral responses to uncertainty, perceived implications of uncertainty, and attempts to control the future. This scale uses a five-point, Likert-type scale ranging from 1 ("Not at all characteristic of me") to 5 ("Entirely characteristic of me"). Possible total scores range from 12 to 60. Greater uncertainty is indicated by higher scores.
Time frame: Immediately after the intervention
Intolerance of Uncertainty-12
This scale is a 12-item scale for measuring trait Intolerance of Uncertainty. it is used for assessing the degree to which individuals are able to tolerate the uncertainty of ambiguous situations, the cognitive and behavioral responses to uncertainty, perceived implications of uncertainty, and attempts to control the future. This scale uses a five-point, Likert-type scale ranging from 1 ("Not at all characteristic of me") to 5 ("Entirely characteristic of me"). Possible total scores range from 12 to 60. Greater uncertainty is indicated by higher scores.
Time frame: Follow-Up, 1 month after the intervention
Intolerance of Uncertainty-12
This scale is a 12-item scale for measuring trait Intolerance of Uncertainty. it is used for assessing the degree to which individuals are able to tolerate the uncertainty of ambiguous situations, the cognitive and behavioral responses to uncertainty, perceived implications of uncertainty, and attempts to control the future. This scale uses a five-point, Likert-type scale ranging from 1 ("Not at all characteristic of me") to 5 ("Entirely characteristic of me"). Possible total scores range from 12 to 60. Greater uncertainty is indicated by higher scores.
Time frame: Follow-Up, 3 months after the intervention
Insomnia Severity Index (ISI)
The ISI is a seven-item self-report questionnaire designed to assess sleep difficulties (i.e., falling asleep, staying asleep, waking too early), satisfaction/dissatisfaction with sleep patterns, and/or interference with daily functioning. Participants will be asked to rate each item using a five-point Likert-type scale ranging from zero to four. Possible total scores range from 0 to 28. Higher scores reflecting more severe sleep problems and greater dissatisfaction with sleep.
Time frame: Baseline, pre-intervention
Insomnia Severity Index (ISI)
The ISI is a seven-item self-report questionnaire designed to assess sleep difficulties (i.e., falling asleep, staying asleep, waking too early), satisfaction/dissatisfaction with sleep patterns, and/or interference with daily functioning. Participants will be asked to rate each item using a five-point Likert-type scale ranging from zero to four. Possible total scores range from 0 to 28. Higher scores reflecting more severe sleep problems and greater dissatisfaction with sleep.
Time frame: Immediately after the intervention
Insomnia Severity Index (ISI)
The ISI is a seven-item self-report questionnaire designed to assess sleep difficulties (i.e., falling asleep, staying asleep, waking too early), satisfaction/dissatisfaction with sleep patterns, and/or interference with daily functioning. Participants will be asked to rate each item using a five-point Likert-type scale ranging from zero to four. Possible total scores range from 0 to 28. Higher scores reflecting more severe sleep problems and greater dissatisfaction with sleep.
Time frame: Follow-Up, 1 month after the intervention
Insomnia Severity Index (ISI)
The ISI is a seven-item self-report questionnaire designed to assess sleep difficulties (i.e., falling asleep, staying asleep, waking too early), satisfaction/dissatisfaction with sleep patterns, and/or interference with daily functioning. Participants will be asked to rate each item using a five-point Likert-type scale ranging from zero to four. Possible total scores range from 0 to 28. Higher scores reflecting more severe sleep problems and greater dissatisfaction with sleep.
Time frame: Follow-Up, 3 months after the intervention
Depressive Symptom Index - Suicidality Subscale (DSI-SS)
The DSI-SS is a 4-item measure of symptoms of suicide. The DSI-SS was designed to be a brief screening measure for suicide risk, and has well established cut points for clinical and research utility. Participants are asked to rate each item using a scale that ranges from 0 to 3 (total score range 0-12), with higher scores reflecting greater severity of suicidal ideation.
Time frame: Baseline, pre-intervention
Depressive Symptom Index - Suicidality Subscale (DSI-SS)
The DSI-SS is a 4-item measure of symptoms of suicide. The DSI-SS was designed to be a brief screening measure for suicide risk, and has well established cut points for clinical and research utility. Participants are asked to rate each item using a scale that ranges from 0 to 3 (total score range 0-12), with higher scores reflecting greater severity of suicidal ideation.
Time frame: Immediately after the intervention
Depressive Symptom Index - Suicidality Subscale (DSI-SS)
The DSI-SS is a 4-item measure of symptoms of suicide. The DSI-SS was designed to be a brief screening measure for suicide risk, and has well established cut points for clinical and research utility. Participants are asked to rate each item using a scale that ranges from 0 to 3 (total score range 0-12), with higher scores reflecting greater severity of suicidal ideation.
Time frame: Follow-Up, 1 month after the intervention
Depressive Symptom Index - Suicidality Subscale (DSI-SS)
The DSI-SS is a 4-item measure of symptoms of suicide. The DSI-SS was designed to be a brief screening measure for suicide risk, and has well established cut points for clinical and research utility. Participants are asked to rate each item using a scale that ranges from 0 to 3 (total score range 0-12), with higher scores reflecting greater severity of suicidal ideation.
Time frame: Follow-Up, 3 months after the intervention
Alcohol Use Disorder Identification Test (AUDIT)
The AUDIT is a 10-item questionnaire that assesses alcohol consumption, drinking behavior, and alcohol-related problems. The AUDIT will be administered to assess drinking behavior. For items 1-8, participants are asked to rate each item using a scale that ranges from 0 to 4. For items 9 and 10, participants are asked to choose from possible responses of 0, 2 and 4. Possible total scores range from 0 to 40. Greater alcohol consumption, drinking behavior, and alcohol-related problems is indicated by higher scores.
Time frame: Baseline, pre-intervention
Alcohol Use Disorder Identification Test (AUDIT)
The AUDIT is a 10-item questionnaire that assesses alcohol consumption, drinking behavior, and alcohol-related problems. The AUDIT will be administered to assess drinking behavior. For items 1-8, participants are asked to rate each item using a scale that ranges from 0 to 4. For items 9 and 10, participants are asked to choose from possible responses of 0, 2 and 4. Possible total scores range from 0 to 40. Greater alcohol consumption, drinking behavior, and alcohol-related problems is indicated by higher scores.
Time frame: Immediately after the intervention
Alcohol Use Disorder Identification Test (AUDIT)
The AUDIT is a 10-item questionnaire that assesses alcohol consumption, drinking behavior, and alcohol-related problems. The AUDIT will be administered to assess drinking behavior. For items 1-8, participants are asked to rate each item using a scale that ranges from 0 to 4. For items 9 and 10, participants are asked to choose from possible responses of 0, 2 and 4. Possible total scores range from 0 to 40. Greater alcohol consumption, drinking behavior, and alcohol-related problems is indicated by higher scores.
Time frame: Follow-Up, 1 month after the intervention
Alcohol Use Disorder Identification Test (AUDIT)
The AUDIT is a 10-item questionnaire that assesses alcohol consumption, drinking behavior, and alcohol-related problems. The AUDIT will be administered to assess drinking behavior. For items 1-8, participants are asked to rate each item using a scale that ranges from 0 to 4. For items 9 and 10, participants are asked to choose from possible responses of 0, 2 and 4. Possible total scores range from 0 to 40. Greater alcohol consumption, drinking behavior, and alcohol-related problems is indicated by higher scores.
Time frame: Follow-Up, 3 months after the intervention
Drug Use Disorders Identification Test (DUDIT)
The DUDIT is an 11-item questionnaire that assesses drug consumption, drug use behavior, and drug-related problems. The DUDIT will be administered to assess drug use behavior. For items 1-9, participants are asked to rate each item using a scale that ranges from 0 to 4. For items 10 and 11, participants are asked to choose from possible responses of 0, 2 and 4. Possible total scores range from 0 to 44. Greater drug consumption, drug use behavior, and drug-related problems is indicated by higher scores.
Time frame: Baseline, pre-intervention
Drug Use Disorders Identification Test (DUDIT)
The DUDIT is an 11-item questionnaire that assesses drug consumption, drug use behavior, and drug-related problems. The DUDIT will be administered to assess drug use behavior. For items 1-9, participants are asked to rate each item using a scale that ranges from 0 to 4. For items 10 and 11, participants are asked to choose from possible responses of 0, 2 and 4. Possible total scores range from 0 to 44. Greater drug consumption, drug use behavior, and drug-related problems is indicated by higher scores.
Time frame: Immediately after the intervention
Drug Use Disorders Identification Test (DUDIT)
The DUDIT is an 11-item questionnaire that assesses drug consumption, drug use behavior, and drug-related problems. The DUDIT will be administered to assess drug use behavior. For items 1-9, participants are asked to rate each item using a scale that ranges from 0 to 4. For items 10 and 11, participants are asked to choose from possible responses of 0, 2 and 4. Possible total scores range from 0 to 44. Greater drug consumption, drug use behavior, and drug-related problems is indicated by higher scores.
Time frame: Follow-Up, 1 month after the intervention
Drug Use Disorders Identification Test (DUDIT)
The DUDIT is an 11-item questionnaire that assesses drug consumption, drug use behavior, and drug-related problems. The DUDIT will be administered to assess drug use behavior. For items 1-9, participants are asked to rate each item using a scale that ranges from 0 to 4. For items 10 and 11, participants are asked to choose from possible responses of 0, 2 and 4. Possible total scores range from 0 to 44. Greater drug consumption, drug use behavior, and drug-related problems is indicated by higher scores.
Time frame: Follow-Up, 3 months after the intervention
Fear of Arousal Questionnaire (FAQ)
The FAQ is a 12-item self-report measure of fear of arousal. Fear of arousal is defined as the fear of the physiological responses that are typical of anxiety (e.g., racing thoughts, racing heart, or throat tightening). The measure asks participants to rate each item on a 1 to 5 scale with 1 corresponding to no anxiety and 5 corresponding to extreme anxiety. Possible total scores range from 12 to 60. Greater fear of arousal is indicated by higher scores.
Time frame: Baseline, pre-intervention
Fear of Arousal Questionnaire (FAQ)
The FAQ is a 12-item self-report measure of fear of arousal. Fear of arousal is defined as the fear of the physiological responses that are typical of anxiety (e.g., racing thoughts, racing heart, or throat tightening). The measure asks participants to rate each item on a 1 to 5 scale with 1 corresponding to no anxiety and 5 corresponding to extreme anxiety. Possible total scores range from 12 to 60. Greater fear of arousal is indicated by higher scores.
Time frame: Immediately after the intervention
Fear of Arousal Questionnaire (FAQ)
The FAQ is a 12-item self-report measure of fear of arousal. Fear of arousal is defined as the fear of the physiological responses that are typical of anxiety (e.g., racing thoughts, racing heart, or throat tightening). The measure asks participants to rate each item on a 1 to 5 scale with 1 corresponding to no anxiety and 5 corresponding to extreme anxiety. Possible total scores range from 12 to 60. Greater fear of arousal is indicated by higher scores.
Time frame: Follow-Up, 1 month after the intervention
Fear of Arousal Questionnaire (FAQ)
The FAQ is a 12-item self-report measure of fear of arousal. Fear of arousal is defined as the fear of the physiological responses that are typical of anxiety (e.g., racing thoughts, racing heart, or throat tightening). The measure asks participants to rate each item on a 1 to 5 scale with 1 corresponding to no anxiety and 5 corresponding to extreme anxiety. Possible total scores range from 12 to 60. Greater fear of arousal is indicated by higher scores.
Time frame: Follow-Up, 3 months after the intervention
National Institutes of Health (NIH) Toolbox Loneliness Scale
The NIH Toolbox Loneliness Scale is a 5-item scale belonging to the NIH Toolbox Adult Social Relationship Scales. This brief scale was developed to measure perceived loneliness, or the perception that one is lonely or socially isolated from others. The measure asks participants to rate each item on a 1 ("Never") to 5 ("Always") scale. Possible total scores range from 5 to 25. Greater loneliness is indicated by higher scores.
Time frame: Baseline, pre-intervention
National Institutes of Health (NIH) Toolbox Loneliness Scale
The NIH Toolbox Loneliness Scale is a 5-item scale belonging to the NIH Toolbox Adult Social Relationship Scales. This brief scale was developed to measure perceived loneliness, or the perception that one is lonely or socially isolated from others. The measure asks participants to rate each item on a 1 ("Never") to 5 ("Always") scale. Possible total scores range from 5 to 25. Greater loneliness is indicated by higher scores.
Time frame: During the Intervention (Weeks 1-5)
National Institutes of Health (NIH) Toolbox Loneliness Scale
The NIH Toolbox Loneliness Scale is a 5-item scale belonging to the NIH Toolbox Adult Social Relationship Scales. This brief scale was developed to measure perceived loneliness, or the perception that one is lonely or socially isolated from others. The measure asks participants to rate each item on a 1 ("Never") to 5 ("Always") scale. Possible total scores range from 5 to 25. Greater loneliness is indicated by higher scores.
Time frame: Immediately after the intervention
National Institutes of Health (NIH) Toolbox Loneliness Scale
The NIH Toolbox Loneliness Scale is a 5-item scale belonging to the NIH Toolbox Adult Social Relationship Scales. This brief scale was developed to measure perceived loneliness, or the perception that one is lonely or socially isolated from others. The measure asks participants to rate each item on a 1 ("Never") to 5 ("Always") scale. Possible total scores range from 5 to 25. Greater loneliness is indicated by higher scores.
Time frame: Follow-Up, 1 month after the intervention
National Institutes of Health (NIH) Toolbox Loneliness Scale
The NIH Toolbox Loneliness Scale is a 5-item scale belonging to the NIH Toolbox Adult Social Relationship Scales. This brief scale was developed to measure perceived loneliness, or the perception that one is lonely or socially isolated from others. The measure asks participants to rate each item on a 1 ("Never") to 5 ("Always") scale. Possible total scores range from 5 to 25. Greater loneliness is indicated by higher scores.
Time frame: Follow-Up, 3 months after the intervention
Exit Interview
Participants will provide information on how to tailor the intervention, including the order of the components, the amount of homework specific to each component, and the length of time before the booster session to best meet their needs. They will provide this information in a focused feedback session in which they will respond to an investigator-created semi-structured interview.
Time frame: Immediately after the intervention
Ecological Momentary Assessment (EMA) questions
The EMA items include several investigator designed questions asking participants about the impact of the COVID-19 pandemic, sleep quality, and in-the-moment ratings of anxiety, depression, stress, and loneliness. These are the items that participants will complete every morning. Participants will then be asked to rate in-the-moment anxiety, depression, stress, and loneliness and 3 random points throughout the day. Following week 1, participants will receive prompts about coping with anxiety, stress, uncertainty, and loneliness. Following week 1, participants will also be asked to engage in interoceptive exposure exercises, Intolerance of uncertainty exercises, and loneliness exercises. Participants will be asked to describe their experience of engaging in the exercises using the MetricWire app.
Time frame: During the Intervention (Weeks 1-5)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.